DRUG

Bright Minds Biosciences Inc.

HealthcareBiotechnologyCAUSDPeers →Country macro →

$62.45

LiveJun 22, 2026

AI Brief

Market cap

$484.67M

52w range

23.18 – 123.75

P / E

—

EPS

—

Volume

265.81K

Revenue · FY

—

Overview Fundamentals Market Narrative & AI

Explain this page

Arphra AIPlain-English read on Bright Minds Biosciences Inc.’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

No price history in prices_daily for DRUG.

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Analyst PT consensus: $159.50 (+155.42%)

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
+3.08%	+4.58%	-25.11%	-12.69%	-24.67%	-19.87%	+130.82%	+1910.61%	+173.06%	+131.59%	+131.59%

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Aftermarket

Live

Jun 22, 06:43 PM

Last trade

$62.53

427 sh

Bid

$60.70

4 sh

Ask

$62.57

1 sh

Spread

$1.870

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Real Estate
+1.52%
Industrials
+0.81%
Basic Materials
+0.81%
Energy
+0.53%
Healthcare
+0.52%
Utilities
-0.05%
Consumer Defensive
-0.20%
Consumer Cyclical
-0.22%
Financial Services
-0.41%
Communication Services
-0.90%
Technology
-1.27%

Top industries (issuer's industry highlighted)

Biotechnology
+7.01%
Financial - Mortgages
-4.16%
Electronic Gaming & Multimedia
-3.62%
Software - Infrastructure
-3.55%
Oil & Gas Energy
-3.00%
Apparel - Footwear & Accessories
-2.57%
Staffing & Employment Services
-2.51%
Electrical Equipment & Parts
+2.43%
REIT - Specialty
+2.34%
Independent Power Producers
+2.18%
Residential Construction
+2.14%
Agricultural - Machinery
+2.05%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for DRUG.

Recent analyst activity

2 latest

Jun 02, 2026GradeBuy → BuyH.C. Wainwright Reiterates Buy Rating on Bright Minds Biosciences Inc. (DRUG)H.C. Wainwright
Jun 02, 2026PT$145.00H.C. Wainwright Reiterates Buy Rating on Bright Minds Biosciences Inc. (DRUG)H.C. Wainwright

Peers

No peer list available for DRUG.

Total assets

—

Total debt

—

Cash & equiv

—

Operating CF

—

Free cash flow

—

Buybacks

—

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin